[Combination therapy with antibacterial chemotherapeutic agents in staphylococcal infections].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D005672:Fusidic Acid / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008712:Methicillin / Q000627:therapeutic use*; D008875:Middle Aged; D009675:Novobiocin / Q000627:therapeutic use*; D010403:Penicillin Resistance; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy; D012293:Rifampin / Q000627:therapeutic use*; D018805:Sepsis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy*
D009675:Novobiocin; D005672:Fusidic Acid; D004917:Erythromycin; D008712:Methicillin; D012293:Rifampin
Kombinationsbehandling med antibakterielle kemoterapeutika ved stafylokokinfektioner.